The overall impact of AMPK activation on lipolysis remains controversial, and future studies are needed to elucidate the effects of chronic AMPK activation on tissue specificity and systemic lipid metabolism, which may have crucial implications for the treatment of obesity. The gene discussed is PRKAA1; the disease is obesity disorder.